Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?

Tahan V., Ozaras R., Karaca C., Uraz S., EREN F., Danalioglu A., ...More

HEPATO-GASTROENTEROLOGY, vol.56, pp.1425-1428, 2009 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 56
  • Publication Date: 2009
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1425-1428
  • Istanbul University Affiliated: Yes


Background/Aims: The management of chronic hepatitis C virus (HCV) infection is costly. Genotyping determines the indication, probability of response.. and duration of treatment and the dose of ribavirin. Although genotyping is accepted cost-effective, the cost of genotyping in all of the patients to find out a minority may offset the gain.